procysteine
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 2, 1999 (NCT00002114)
Timeline
1990s
- Jan 1, 1999
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
O=C1N[C@H](C(=O)O)CS1- Mol. weight
- 147.16 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL442218 ↗
Also known as
- 2-oxo-4-thiazolidine carboxylic acid
- 2-oxothiazolidine-4-carboxylate
- 2-oxothiazolidine-4-carboxylic acid
- 2-oxothiazolidine-4-carboxylic acid, (r)-isomer
- 2-oxothiazolidine-4-carboxylic acid, (s)-isomer
- 4-thiazolidinecarboxylic acid, 2-oxo-
- l-2-otzd-4-cxa
- l-2-oxothiazolidine-4-carboxylate
- oxothiazolidinecarboxylic acid
- oxothiazolidinecarboxylic acid
- oxothiazolidinecarboxylic acid
- procysteine
- procysteine
- procysteine
- procysteine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00002114 | Phase 2 | Nov 2, 1999 | Transcend Medical |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Transcend Medical | For profit | 1 | 1 | 1 | 1999 |
1 organizations
Page 1 / 1